Q2 and H1 FY26 saw double-digit revenue and EBITDA growth, with margins stable despite new bed additions. Dombivli Hospital is on track for Q1 launch next year, with new accounting for unbilled revenue and a one-off provision impacting results. Debt remains low-cost and well-covered by liquidity.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.